Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
about
Epstein-Barr virus latent membrane protein 1 (LMP1) C-terminal-activating region 3 contributes to LMP1-mediated cellular migration via its interaction with Ubc9The Epstein-Barr virus oncoprotein latent membrane protein 1 engages the tumor necrosis factor receptor-associated proteins TRADD and receptor-interacting protein (RIP) but does not induce apoptosis or require RIP for NF-kappaB activationIdentification of transmembrane protein 134 as a novel LMP1-binding protein by using bimolecular fluorescence complementation and an enhanced retroviral mutagenThe Epstein-Barr virus oncogene product latent membrane protein 1 engages the tumor necrosis factor receptor-associated death domain protein to mediate B lymphocyte growth transformation and activate NF-kappaBThe viral etiology of AIDS-associated malignanciesEpstein-Barr virus latent genesEpstein-Barr virus associated modulation of Wnt pathway is not dependent on latent membrane protein-1.Role of the TRAF binding site and NF-kappaB activation in Epstein-Barr virus latent membrane protein 1-induced cell gene expressionInteraction of tumor necrosis factor receptor-associated factor signaling proteins with the latent membrane protein 1 PXQXT motif is essential for induction of epidermal growth factor receptor expressionHairy leukoplakia: an unusual combination of transforming and permissive Epstein-Barr virus infections.Matrix metalloproteinase 9 expression is induced by Epstein-Barr virus latent membrane protein 1 C-terminal activation regions 1 and 2.An Epstein-Barr virus that expresses only the first 231 LMP1 amino acids efficiently initiates primary B-lymphocyte growth transformationInterferon regulatory factor 7 mediates activation of Tap-2 by Epstein-Barr virus latent membrane protein 1.TNF receptor (TNFR)-associated factor (TRAF) 3 serves as an inhibitor of TRAF2/5-mediated activation of the noncanonical NF-kappaB pathway by TRAF-binding TNFRsIntracellular signaling molecules activated by Epstein-Barr virus for induction of interferon regulatory factor 7.Latent membrane protein 1 of Epstein-Barr virus interacts with JAK3 and activates STAT proteinsHuman Cytomegalovirus Latency: Approaching the Gordian Knot.Molecular virology of Epstein-Barr virus.Latent membrane protein 1 of Epstein-Barr virus mimics a constitutively active receptor molecule.Human papillomavirus and Epstein-Barr virus co-infection in cervical carcinoma in Algerian women.Lymphocyte deficiency limits Epstein-Barr virus latent membrane protein 1 induced chronic inflammation and carcinogenic pathology in vivoLMP1 strain variants: biological and molecular properties.Latent infection membrane protein transmembrane FWLY is critical for intermolecular interaction, raft localization, and signaling.LMP1 transmembrane domain 1 and 2 (TM1-2) FWLY mediates intermolecular interactions with TM3-6 to activate NF-kappaBEpstein-Barr virus latent-infection membrane proteins are palmitoylated and raft-associated: protein 1 binds to the cytoskeleton through TNF receptor cytoplasmic factors.Changes in expression induced by Epstein-Barr Virus LMP1-CTAR1: potential role of bcl3.LMP1-Induced Sumoylation Influences the Maintenance of Epstein-Barr Virus Latency through KAP1The Epstein-Barr virus LMP1 amino acid sequence that engages tumor necrosis factor receptor associated factors is critical for primary B lymphocyte growth transformation.The expression of matrix metalloproteinase 9 is enhanced by Epstein-Barr virus latent membrane protein 1Opposing Regulation of the EGF Receptor: A Molecular Switch Controlling Cytomegalovirus Latency and Replication.Unique signaling properties of CTAR1 in LMP1-mediated transformation.Phosphorylated ezrin is associated with EBV latent membrane protein 1 in nasopharyngeal carcinoma and induces cell migration.EBV-encoded latent membrane protein 1 cooperates with BAFF/BLyS and APRIL to induce T cell-independent Ig heavy chain class switchingInduction of cyclooxygenase-2 by Epstein-Barr virus latent membrane protein 1 is involved in vascular endothelial growth factor production in nasopharyngeal carcinoma cells.Epstein-Barr virus-transforming protein latent infection membrane protein 1 activates transcription factor NF-kappaB through a pathway that includes the NF-kappaB-inducing kinase and the IkappaB kinases IKKalpha and IKKbetaExpression of the Epstein-Barr virus latent membrane protein 1 induces B cell lymphoma in transgenic mice.Epstein-Barr virus latent membrane protein 1 regulates the function of interferon regulatory factor 7 by inducing its sumoylation.Requirement for TRAF3 in signaling by LMP1 but not CD40 in B lymphocytesThe role of A20 in the pathogenesis of lymphocytic malignancy.Nuclear factor kappa B-dependent activation of the antiapoptotic bfl-1 gene by the Epstein-Barr virus latent membrane protein 1 and activated CD40 receptor.
P2860
Q24317074-930A7122-E7FB-4EAB-91EC-E3A7BCA5DCFBQ24554457-CDACFA05-6895-4B25-8BA8-2FBB07755AAEQ24633907-3F6185B5-8A66-40AE-A61A-7FCAE4ABA9DAQ24646694-4F01E0FC-98EC-48F3-AE36-D3540B62902BQ24685892-38798AB2-37CC-4D4D-8E86-E42A6C8A38EEQ28082701-4E85EB8C-7359-43A7-AD52-59026EBA58A4Q33370930-7C63A22D-B122-4D57-AD06-C186FC5ADE79Q33784729-F3199471-A2DE-4714-AA31-2615EAD866F2Q33786551-0C07EB38-930D-48DF-943F-E75ABE528DDDQ33809963-3DD8565A-B37C-487E-A8FB-B9FD8CE1394BQ33815241-AFEB00D1-8A76-449C-BE54-68CE8710224FQ33825713-39C9F3BB-ADCF-48B1-9FBC-B8E31A6056CEQ33834888-9A7FEF41-D447-4318-8049-2004DD31F364Q33864629-E7569B5C-5DA8-47BB-A3A6-83EB20BD6D45Q33870488-0CECCD87-F18C-45A0-B5BF-199A50C1B133Q33891012-4944A25B-F275-4D6F-8280-6CF4AC71FAF4Q33912815-0FEDFEAC-D8C4-4392-8F91-3B663AB37D74Q34225554-0F86D7BD-34B6-4A9C-9F82-87BBF72825CAQ34250209-4F6183C4-E753-4FE0-8FF5-5431B5911F58Q34477653-481736C5-27DB-4270-B7C1-DFB9E9D966F2Q34586289-02DFC9AC-D2D0-4674-82E5-23D8D13818D9Q34717145-69572C75-AE42-454E-B790-BAF210419D10Q35122447-26921B53-D6E4-4593-8CB6-A13D0AF8D473Q35139273-8C4C81B0-3C7D-42A5-9FF0-1256DD49F95FQ35291650-04928D7F-7F4E-40C5-A51C-99E00FBFC851Q35677629-F8ED9055-D590-4783-BA54-99FBB2B6F981Q35861199-2033A80F-56D5-4356-A05B-53E308FFA270Q35997566-D871314A-3B97-4FE0-B96B-15BC36DC96EBQ36006767-F28D95F0-D35F-426D-B006-D67401C704F2Q36027770-4D0D3202-9377-4C23-A4FF-ED7071EC9EE1Q36098869-0A40BD6B-A0FA-482F-8CB1-2CC66F1DE8E6Q36174662-F79CC64D-F6EE-4EDB-8ED8-23F5411C624AQ36222552-3131E1ED-0273-4D75-894F-96860D3A496CQ36242117-0EF499CD-96BB-4F18-A70A-D3D1C39ABD5EQ36285724-1DD1F0C0-24F5-4603-BE5B-96035052A9F2Q36327458-3C6D3DA7-3AE6-4E3E-AFB7-E03B9494AA4FQ36363843-BE7DDC28-F525-4A17-87D7-52D5EED8B4BAQ36403897-E79327CE-767E-4239-A525-E97D18F666A2Q36455774-76173B6E-5A3A-4B3D-9210-16E5293CDCE2Q36961875-88365782-EF90-4F06-8147-D02E2469EF67
P2860
Epstein-Barr virus LMP1 induction of the epidermal growth factor receptor is mediated through a TRAF signaling pathway distinct from NF-kappaB activation.
description
1997 nî lūn-bûn
@nan
1997年の論文
@ja
1997年学术文章
@wuu
1997年学术文章
@zh-cn
1997年学术文章
@zh-hans
1997年学术文章
@zh-my
1997年学术文章
@zh-sg
1997年學術文章
@yue
1997年學術文章
@zh
1997年學術文章
@zh-hant
name
Epstein-Barr virus LMP1 induct ...... nct from NF-kappaB activation.
@ast
Epstein-Barr virus LMP1 induct ...... nct from NF-kappaB activation.
@en
type
label
Epstein-Barr virus LMP1 induct ...... nct from NF-kappaB activation.
@ast
Epstein-Barr virus LMP1 induct ...... nct from NF-kappaB activation.
@en
prefLabel
Epstein-Barr virus LMP1 induct ...... nct from NF-kappaB activation.
@ast
Epstein-Barr virus LMP1 induct ...... nct from NF-kappaB activation.
@en
P2093
P2860
P1433
P1476
Epstein-Barr virus LMP1 induct ...... nct from NF-kappaB activation.
@en
P2093
G Mosialos
N Raab-Traub
W E Miller
P2860
P304
P407
P577
1997-01-01T00:00:00Z